期刊文献+

肌酐、肌钙蛋白在不同AECOPD严重程度中的变化

Changes of Creatinine and Troponin in Patients with Different Degrees of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
下载PDF
导出
摘要 目的:研究不同AECOPD严重程度中肌酐及肌钙蛋白的变化。方法:纳入2015年2月~2016年8月我院收治的164例AECOPD患者为研究对象,依据患者肺功能损伤程度以及临床表现差异分为轻度组(n=42)、中度组(n=64)、重度组(n=58),对比三组肌酐、肌钙蛋白水平,并找出其变化规律。结果:三组患者肌酐、肌钙蛋白水平对比差异具有显著性(P<0.05);随着病情加深,FEV1/预计值%减小,而肌酐、肌钙蛋白水平和FEV1/预计值%呈负相关性。结论:肌酐、肌钙蛋白水平和FEV1/预计值%呈负相关性,可将慢性阻塞性肺病患者肾功能损坏及心肌细胞损害程度体现出来。 Objective: To study the changes ofcreatinine and troponin in patients with different degrees of acute exacerbations of Chronic obstructive pulmonary disease (AECOPD). Methods: A total of 164 patients with AECOPD were admitted and treated in our hospital from February 2015 to August 2016 as the objects of study. According to the damage degree of pulmonary function, they were divided into mild group (n=42), moderate group (n=64), and severe group (n=58). The levels ofcreatinine and troponin were compared in three groups for understanding the pattern of changes.Results: There were significant differences among three groups in creatinine and troponin (P 〈 0.05). The predicted values of FEV1 decrease as the disease got worse, but negatively related to creatinine and troponin. Conclusions: There is negative correlation between creatinine, troponin, and FEV1, which can reflect the damage degree of pulmonary function and cardiomyocytes in patients with AECOPD.
作者 梁栋 吕孟良 常青 王莹 王明明 Dong Liang Mengliang Lv Qing Chang Ying Wang Mingming Wang(Department of Laboratory, Chinese Traditional Medical Hospital of Zhoukou, Zhoukou, Henan 466000, Chin)
出处 《西藏医药》 2017年第3期1-3,共3页 Tibetan Medicine
关键词 肌酐 肌钙蛋白 AECOPD严重程度 变化 Creatinine Troponin AECOPD Severity Changes
  • 相关文献

参考文献7

二级参考文献66

  • 1叶永青.慢性阻塞性肺病患者血浆B-型钠尿肽水平及临床意义[J].实用临床医药杂志,2005,9(8):14-16. 被引量:18
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8233
  • 3籍振国,刘刚,刘超,吉立双,刘坤申.大剂量螺内酯与糖皮质激素联合治疗重症慢性心力衰竭的临床观察[J].临床荟萃,2007,22(11):771-774. 被引量:10
  • 4Stolg D,Rasch H,Linka A,et al.A randomized controlled trial of bsentan in severe COPD[J].Eur Respir J,2008,32:619-628.
  • 5Leuchte HH,Baumgartner RA,Hounou ME,et al.Brain natriuretic peptide is a prognostic parameter in chronic lung disease[J].Am J Respir Crit Care Med,2006,173:744-750.
  • 6朱元钰,陈文斌.呼吸病学[M].第1版.北京:人民卫生出版社,2007,877-892.
  • 7Kardos P,Wencher M,Glaab T,et al.Impact of salmeterol fluticasone propionate versus salmeterol on exacerbations in severe chronic obstruction pulmonary disease[J].Am J Respire Crit Care Med,2007,175:144-149.
  • 8Hopkins WE,Chen Z,Fukagawa NK,et al.Increased atrial and brain natriuretic peptide in adults with congenital heart disease,enhanced understanding of the relationship hypoxia and natriuretic peptide secretion[J].Circulation,2004,109:2872-2876.
  • 9Tashkin DP,Cell B,Senn S,et al.A4-year trial of tiotropinum in chronic obstructive pulmonary disease[J].N Engl J Med,2008,359:1543-1554.
  • 10Sin DD,Man SF.Is systemic inflammation responsible for pulmonary hypertension in COPD?[J] Chest,2006,130:310-312.

共引文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部